New NIH-funded Center Could Soon Reduce the Need for Pharmaceutical Trials on Animals
Tuesday, January 9, 2024
Rochester is one of four NIH-sponsored centers that aims to produce tissue-on-chip devices as FDA-qualified drug development tools. The center aims to develop five Food and Drug Administration–qualified drug development tools related to study barrier functions in disease—interfaces in tissue that are critical for the progression of infection, cancer, and many autoimmune disorders.
Read More: New NIH-funded Center Could Soon Reduce the Need for Pharmaceutical Trials on Animals